Sacubitril/valsartan (Entresto)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Sacubitril/valsartan (Entresto), covering 2025-08-03 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction